Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App





New Pipetting Robot Automates COVID-19 Testing Processes to Reduce Repetitive Work and Accidents

By LabMedica International staff writers
Posted on 24 Jun 2020
A new pipetting robot is automating COVID-19 testing processes in European hospitals, thereby significantly reducing the time taken by laboratories to generate results.

The liquid handling robot named flowbot ONE developed by Flow Robotics (Copenhagen, Denmark) makes automating pipetting simple with an intuitive user interface that can be mastered in just one hour. More...
The company has termed flowbot ONE as a liquid handling cobot as it collaborates with the user in the lab, assisting in workflows and adapting to the lab. It does not require programming, extensive training, or a long implementation period. With flowbot ONE, these steps can be skipped and automation can be started immediately. The highly precise system ensures accurate and consistent pipetting and results, saving time as well as increasing safety by minimizing manual handling of pathogenic strains.

A plug and play solution with high accuracy and precision, flowbot ONE allows the user to customize components and liquid classes easily, edit, copy and share existing programs. It offers a range of functions to ease the workflow such as two pipette modules (choice between 1, 4 and 8-channel), volume ranges of 1-20μL, 2-200μL and 10-1000μL, 12 capacity positions (SBS format), and automatic liquid level detection. flowbot ONE has taken over the massive workload of COVID-19 sample preparation in hospitals across Europe.

“Our stress levels have decreased in many ways: less repetitive work, and fewer potential errors. While the robot is pipetting, we can perform other tasks, accelerating the speed of the COVID-19 tests we are performing,” said Martin Friis, a molecular biologist at Herlev Hospital.

Related Links:
Flow Robotics


Gold Member
Universal Transport Solution
Puritan®UniTranz-RT
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Automatic CLIA Analyzer
Shine i9000
6 Part Hematology Analyzer with RET + IPF
Mispa HX 88
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.